To determine the PANAMutyperTM R EGFR and KRAS sensitivity for each tested mutation, genomic DNA (gDNA) from the mutant cell line containing the tested mutation was serially diluted 5 times into highly concentrated WT gDNA from the human lung cancer cell line A549. The gene discussed is KRAS; the disease is lung carcinoma.